Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multicenter Safety and Feasibility Study of the Juveena Hydrogel System for Use for Temporary Control of Chronic Ovulatory Heavy Menstrual Bleeding (HMB)

NCT06634719 is registered in ClinicalTrials.gov with Rejoni Inc. as lead sponsor.

NCT NCT06634719
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06634719 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multicenter Safety and Feasibility Study of the Juveena Hydrogel System for Use for Temporary Control of Chronic Ovulatory Heavy Menstrual Bleeding (HMB)
Lead sponsor
Rejoni Inc.
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2025
Completion date
May 22, 2026
Enrollment
13 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

heavy menstrual bleeding